CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 4 Open-market buy Director bought 10,000 shares at $0.70 ($7,000)
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Delisting notice
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 4 of 33 · 643 filings